Attention deficit hyperactivity disorder has been the subject of sustained clinical investigation across multiple research sites.

27 total trials for this combination

Showing top 10 of 27 trials

Trials

NCT ID	Title	Status	Phase
NCT00877487	Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder	COMPLETED	PHASE4
NCT01239030	Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD	COMPLETED	PHASE3
NCT01074294	Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder	COMPLETED	PHASE2
NCT01552902	Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder	COMPLETED	PHASE4
NCT01081132	Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl	COMPLETED	PHASE3
NCT00997984	Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)	COMPLETED	PHASE3
NCT01552915	Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder	COMPLETED	PHASE4
NCT00880217	A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)	COMPLETED	PHASE2
NCT01081145	Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)	COMPLETED	PHASE3
NCT01259492	Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)	COMPLETED	PHASE3

Related Pages

All Attention deficit hyperactivity disorder trials All trials in Bradenton, United States